All In Biotech

Drug Trial Radar · NCT07462130

An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)

A Phase Ib/II, Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)

Last checked: Nov 19, 2026Latest source record: Mar 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

74

Planned (sponsor's estimate)

Start

Mar 1, 2026

Primary completion

May 31, 2027

Study completion Mar 30, 2028

Sponsor

Sponsor type
Industry
First posted
Mar 10, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multicentre, Phase Ib/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of NTB003 in Participants with Thyroid Eye Disease

Conditions

  • Thyroid Eye Disease

Interventions

  • NTB003Drug

    NTB003 dose 1 administered SC injection every 4 weeks.

  • NTB003Drug

    NTB003 dose 2 administered SC injection every 4 weeks.

  • NTB003Drug

    NTB003 dose 3 administered SC injection every 4 weeks.

  • NTB003 and PlaceboDrug

    Drug:NTB003 subcutaneous injection Drug: Placebo subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proptosis Responder Rate in the study eyeTime frame: Week 12

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.